Literature DB >> 33573266

SSnet: A Deep Learning Approach for Protein-Ligand Interaction Prediction.

Niraj Verma1, Xingming Qu2, Francesco Trozzi1, Mohamed Elsaied3, Nischal Karki1, Yunwen Tao1, Brian Zoltowski1, Eric C Larson2, Elfi Kraka1.   

Abstract

Computational prediction of Protein-Ligand Interaction (PLI) is an important step in the modern drug discovery pipeline as it mitigates the cost, time, and resources required to screen novel therapeutics. Deep Neural Networks (DNN) have recently shown excellent performance in PLI prediction. However, the performance is highly dependent on protein and ligand features utilized for the DNN model. Moreover, in current models, the deciphering of how protein features determine the underlying principles that govern PLI is not trivial. In this work, we developed a DNN framework named SSnet that utilizes secondary structure information of proteins extracted as the curvature and torsion of the protein backbone to predict PLI. We demonstrate the performance of SSnet by comparing against a variety of currently popular machine and non-Machine Learning (ML) models using various metrics. We visualize the intermediate layers of SSnet to show a potential latent space for proteins, in particular to extract structural elements in a protein that the model finds influential for ligand binding, which is one of the key features of SSnet. We observed in our study that SSnet learns information about locations in a protein where a ligand can bind, including binding sites, allosteric sites and cryptic sites, regardless of the conformation used. We further observed that SSnet is not biased to any specific molecular interaction and extracts the protein fold information critical for PLI prediction. Our work forms an important gateway to the general exploration of secondary structure-based Deep Learning (DL), which is not just confined to protein-ligand interactions, and as such will have a large impact on protein research, while being readily accessible for de novo drug designers as a standalone package.

Entities:  

Keywords:  SSnet; deep learning; drug discovery; protein-ligand interaction

Year:  2021        PMID: 33573266      PMCID: PMC7869013          DOI: 10.3390/ijms22031392

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  76 in total

1.  How significant is a protein structure similarity with TM-score = 0.5?

Authors:  Jinrui Xu; Yang Zhang
Journal:  Bioinformatics       Date:  2010-02-17       Impact factor: 6.937

2.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.

Authors:  Nicolas Triballeau; Francine Acher; Isabelle Brabet; Jean-Philippe Pin; Hugues-Olivier Bertrand
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

3.  Description and recognition of regular and distorted secondary structures in proteins using the automated protein structure analysis method.

Authors:  Sushilee Ranganathan; Dmitry Izotov; Elfi Kraka; Dieter Cremer
Journal:  Proteins       Date:  2009-08-01

Review 4.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

5.  In Need of Bias Control: Evaluating Chemical Data for Machine Learning in Structure-Based Virtual Screening.

Authors:  Jochen Sieg; Florian Flachsenberg; Matthias Rarey
Journal:  J Chem Inf Model       Date:  2019-03-05       Impact factor: 4.956

6.  SCOP: a structural classification of proteins database for the investigation of sequences and structures.

Authors:  A G Murzin; S E Brenner; T Hubbard; C Chothia
Journal:  J Mol Biol       Date:  1995-04-07       Impact factor: 5.469

7.  Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing.

Authors:  Rohan Patil; Suranjana Das; Ashley Stanley; Lumbani Yadav; Akulapalli Sudhakar; Ashok K Varma
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

8.  A Computational Framework Based on Ensemble Deep Neural Networks for Essential Genes Identification.

Authors:  Nguyen Quoc Khanh Le; Duyen Thi Do; Truong Nguyen Khanh Hung; Luu Ho Thanh Lam; Tuan-Tu Huynh; Ngan Thi Kim Nguyen
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

9.  Supervised prediction of drug-target interactions using bipartite local models.

Authors:  Kevin Bleakley; Yoshihiro Yamanishi
Journal:  Bioinformatics       Date:  2009-07-15       Impact factor: 6.937

10.  Open-source platform to benchmark fingerprints for ligand-based virtual screening.

Authors:  Sereina Riniker; Gregory A Landrum
Journal:  J Cheminform       Date:  2013-05-30       Impact factor: 5.514

View more
  5 in total

1.  Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field.

Authors:  Jalil Villalobos-Alva; Luis Ochoa-Toledo; Mario Javier Villalobos-Alva; Atocha Aliseda; Fernando Pérez-Escamirosa; Nelly F Altamirano-Bustamante; Francine Ochoa-Fernández; Ricardo Zamora-Solís; Sebastián Villalobos-Alva; Cristina Revilla-Monsalve; Nicolás Kemper-Valverde; Myriam M Altamirano-Bustamante
Journal:  Front Bioeng Biotechnol       Date:  2022-07-07

2.  Allosteric control of ACE2 peptidase domain dynamics.

Authors:  Francesco Trozzi; Nischal Karki; Zilin Song; Niraj Verma; Elfi Kraka; Brian D Zoltowski; Peng Tao
Journal:  Org Biomol Chem       Date:  2022-05-04       Impact factor: 3.890

Review 3.  Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.

Authors:  Le-le Ma; Hui-Min Liu; Xue-Mei Liu; Xiao-Yu Yuan; Chao Xu; Fang Wang; Jun-Zhi Lin; Run-Chun Xu; Ding-Kun Zhang
Journal:  Eur J Med Chem       Date:  2021-10-04       Impact factor: 6.514

Review 4.  The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.

Authors:  Douglas B Kell
Journal:  Molecules       Date:  2021-09-16       Impact factor: 4.411

Review 5.  Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.

Authors:  Giuseppe Floresta; Chiara Zagni; Davide Gentile; Vincenzo Patamia; Antonio Rescifina
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.